Abstract:Influenza A virus (IAV) causes annual epidemics and occasional pandemics, and is one of the best-characterized human RNA viral pathogens1. However, a physiologically relevant role for the RNA interference (RNAi) suppressor activity of the IAV non-structural protein 1 (NS1), reported over a decade ago2, remains unknown3. Plant and insect viruses have evolved diverse virulence proteins to suppress RNAi as their hosts produce virus-derived small interfering RNAs (siRNAs) that direct specific antiviral defence4–7 by an RNAi mechanism dependent on the slicing activity of Argonaute proteins (AGOs)8,9. Recent studies have documented induction and suppression of antiviral RNAi in mouse embryonic stem cells and suckling mice10,11. However, it is still under debate whether infection by IAV or any other RNA virus that infects humans induces and/or suppresses antiviral RNAi in mature mammalian somatic cells12–21. Here, we demonstrate that mature human somatic cells produce abundant virus-derived siRNAs co-immunoprecipitated with AGOs in response to IAV infection. We show that the biogenesis of viral siRNAs from IAV double-stranded RNA (dsRNA) precursors in infected cells is mediated by wild-type human Dicer and potently suppressed by both NS1 of IAV as well as virion protein 35 (VP35) of Ebola and Marburg filoviruses. We further demonstrate that the slicing catalytic activity of AGO2 inhibits IAV and other RNA viruses in mature mammalian cells, in an interferon-independent fashion. Altogether, our work shows that IAV infection induces and suppresses antiviral RNAi in differentiated mammalian somatic cells.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: whether Influenza A Virus (IAV) can induce and suppress antiviral RNA interference (RNAi) in mature human somatic cells. Specifically, the research aims to verify whether IAV infection can trigger antiviral RNAi and explore how the non - structural protein 1 (NS1) of IAV suppresses this process. In addition, the study also explores the role of other virus - encoded RNAi suppressors (VSRs) in suppressing the production of virus - derived small interfering RNAs (vsiRNAs) in human somatic cells, as well as the role of the cleavage activity of AGO2 in limiting IAV and other RNA virus infections. Research background: - Influenza virus causes epidemics every year and occasionally pandemics, and is one of the most intensively studied human RNA viruses. - It is known that the NS1 protein of IAV has the effect of suppressing RNAi, but its specific role under physiologically relevant conditions remains unclear. - Plant and insect viruses have evolved a variety of virulence proteins to suppress RNAi, because these hosts produce virus - derived small interfering RNAs (siRNAs) and carry out antiviral defense specifically through the RNAi mechanism that depends on the cleavage activity of Argonaute proteins (AGOs). - Although recent studies have documented the induction and suppression of antiviral RNAi in mouse embryonic stem cells and neonatal mice, it is still controversial whether IAV or any other RNA virus infecting humans induces and/or suppresses antiviral RNAi in mature mammalian somatic cells. Research methods and results: - The researchers found that mature somatic cells produce a large number of virus - derived siRNAs that co - immunoprecipitate with AGOs after IAV infection. - Wild - type human Dicer mediates the process of generating vsiRNAs from IAV double - stranded RNA precursors, and this generation is strongly suppressed by the NS1 protein of IAV as well as the VP35 proteins of Ebola and Marburg viruses. - The cleavage - catalytic activity of AGO2 suppresses the infection of IAV and other RNA viruses in mature mammalian cells in an interferon - independent manner. - The study further shows that IAV infection both induces and suppresses antiviral RNAi in differentiated mammalian somatic cells. In conclusion, this work reveals the phenomenon that IAV infection simultaneously induces and suppresses antiviral RNAi in mature human somatic cells, providing a new perspective for understanding how RNA viruses interact with the host's RNAi defense mechanism.

Induction and suppression of antiviral RNA interference by influenza A virus in mammalian cells